The incidence of MUC4 gene mutations was significantly greater in PNH patients (nine out of 25, 36%) than in TE patients (two out of 12, 16.7%) (Table 1 and Figure 1A) (p = .003). The gene discussed is MUC4; the disease is paroxysmal nocturnal hemoglobinuria.